European Archives - Page 323 of 329 - European Medical Journal
×

Browse

01
Nov

Intensity-Modulated Radiotherapy in the Treatment of Pancreatic Adenocarcinoma: A Review
Pancreatic cancer remains one of the leading causes of cancer deaths. Despite improvements in imaging, surgical techniques, chemotherapy agents, and…
01
Nov

Key Advances in the Systemic Therapy for Soft Tissue Sarcomas: Current Status and Future Directions
Soft tissue sarcomas (STS) represent a heterogeneous group of diverse neoplasms of mesenchymal origin. Once relapsed from standard therapy, STS patients…
01
Nov

Yoga as Treatment for Insomnia Among Cancer Patients and Survivors: A Systematic Review
Between 15-90% of cancer patients and survivors report some form of insomnia or sleep quality impairment during and post-treatment, such as excessive…
17
Oct

New Insights into the Definitive Management of Venous Thromboembolism
This educational symposium, supported by an unrestricted educational grant from Daiichi Sankyo, was given at the European Society of Cardiology (ESC)…
17
Oct

EMJ Cardiology 2013
Welcome to the inaugural edition of the European Medical Journal – Diabetes, which hosts in depth commentary from the 49th Annual Meeting of the European…
17
Oct

Ace-Inhibitors and Cardioprotection Open Issues and Future Solutions
The current management of patients with hypertension, especially those with a high risk of coronary artery disease should take into account the role of…
17
Oct

The Changing Landscape in Oral Anticoagulation - The Last Pieces of the Puzzle
Dabigatran, rivaroxaban, apixaban and edoxaban are four new oral anticoagulants (NOACs). There are an increasing number of indications for which these…
17
Oct

Practical Guidance for Stroke Prevention in Atrial Fibrillation – Interactive Case Studies
This Boehringer Ingelheim sponsored satellite symposium was held on 2nd September 2013 as part of the ESC conference, which was hosted this year in…
17
Oct

Managing Thromboembolic Risks of Atrial Fibrillation: Can We Afford Increased Efficacy of the Novel Anticoagulants and Devices?
Ischaemic/embolic complications are the most common severe consequences of atrial fibrillation. Although chronic anticoagulation with warfarin has been…
17
Oct

Atrial Fibrillation in Childhood with Familial Hyperthyroidism in Afro-Caribbeans
Atrial fibrillation (AF) associated with familial hyperthyroidism (FH) spanning three generations concomitantly, is rare. The index case was 10 years old…